相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Phase 2 study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 (CCL2), in metastatic castration-resistant prostate cancer
Kenneth J. Pienta et al.
INVESTIGATIONAL NEW DRUGS (2013)
Regulation of Monocyte Chemoattractant Protein-1 Through Angiotensin II Type 1 Receptor in Prostate Cancer
Suguru Shirotake et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
Targeting monocyte chemotactic protein-1 synthesis with bindarit induces tumor regression in prostate and breast cancer animal models
Massimo Zollo et al.
CLINICAL & EXPERIMENTAL METASTASIS (2012)
Inherited Variants in the Chemokine CCL2 Gene and Prostate Cancer Aggressiveness in a Caucasian Cohort
Tong Sun et al.
CLINICAL CANCER RESEARCH (2011)
CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis
Bin-Zhi Qian et al.
NATURE (2011)
CC chemokine ligand 2 (CCL2) promotes prostate cancer tumorigenesis and metastasis
Jian Zhang et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2010)
Multiple Roles of Chemokine (C-C Motif) Ligand 2 in Promoting Prostate Cancer Growth
Jian Zhang et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)
Targeting Chemokine (C-C motif) Ligand 2 (CCL2) as an Example of Translation of Cancer Molecular Biology to the Clinic
Jian Zhang et al.
MOLECULAR BIOLOGY OF CANCER: TRANSLATION TO THE CLINIC (2010)
Cancer Statistics, 2009
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2009)
A Destructive Cascade Mediated by CCL2 Facilitates Prostate Cancer Growth in Bone
Xin Li et al.
CANCER RESEARCH (2009)
Activation of MCP-1/CCR2 axis promotes prostate cancer growth in bone
Yi Lu et al.
CLINICAL & EXPERIMENTAL METASTASIS (2009)
Chemokine Receptors as Targets for Cancer Therapy
Xuesong Wu et al.
CURRENT PHARMACEUTICAL DESIGN (2009)
Emerging roles of chemokines in prostate cancer
David Vindrieux et al.
ENDOCRINE-RELATED CANCER (2009)
A Novel Recombinant Fusion Protein Encoding a 20-Amino Acid Residue of the Third Extracellular (E3) Domain of CCR2 Neutralizes the Biological Activity of CCL2
Liat Izhak et al.
JOURNAL OF IMMUNOLOGY (2009)
Estrogen-dependent and C-C chemokine receptor-2-dependent pathways determine osteoclast behavior in osteoporosis
Nikolaus B. Binder et al.
NATURE MEDICINE (2009)
Chemokine signaling in cancer: One hump or two?
Joshua B. Rubin
SEMINARS IN CANCER BIOLOGY (2009)
The Chemokine Receptors CXCR4 and CXCR3 in Cancer
Amy M. Fulton
CURRENT ONCOLOGY REPORTS (2009)
The Chemokine CCL2 Increases Prostate Tumor Growth and Bone Metastasis through Macrophage and Osteoclast Recruitment
Kosuke Mizutani et al.
NEOPLASIA (2009)
Multi-faceted roles for CXC-chemokines in prostate cancer progression
David J. J. Waugh et al.
FRONTIERS IN BIOSCIENCE (2008)
Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer: Updated survival in the TAX 327 study
Dominik R. Berthold et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Co-inoculation of prostate cancer cells with U937 enhances tumor growth and angiogenesis in vivo
Matthew Craig et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2008)
A contemporary prognostic nomogram for men with hormone-refractory metastatic prostate cancer: A TAX327 study analysis
Andrew J. Armstrong et al.
CLINICAL CANCER RESEARCH (2007)
Targeting CCL2 with systemic delivery of neutralizing antibodies induces prostate cancer tumor regression in vivo
Robert D. Loberg et al.
CANCER RESEARCH (2007)
CCL2 as an important mediator of prostate cancer growth in vivo through the regulation of macrophage infiltration
Robert D. Loberg et al.
NEOPLASIA (2007)
Monocyte chemotactic protein-1 mediates prostate cancer-induced bone resorption
Yi Lu et al.
CANCER RESEARCH (2007)
Monocyte chemotactic protein-1 (MCP-1) acts as a paracrine and autocrine factor for prostate cancer growth and invasion
Yi Lu et al.
PROSTATE (2006)
Therapeutic options in androgen-independent prostate cancer: building on docetaxel
D Petrylak
BJU INTERNATIONAL (2005)
Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer
IF Tannock et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Characterization of C4-2 prostate cancer bone metastases and their response to castration
J Pfitzenmaier et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2003)
LuCaP 35: A new model of prostate cancer progression to androgen independence
E Corey et al.
PROSTATE (2003)
Establishment and characterization of osseous prostate cancer models: Intra tibial injection of human prostate cancer cells
E Corey et al.
PROSTATE (2002)
分享论文
